Editor’s Pick – Bullvesting Insider

Editor's Pick

Europe bulletin: FTSE 100 surge, defense pivot, Kremlin drone claim

European markets and politics closed the year on sharply diverging trajectories.London stocks delivered their strongest performance since the financial crisis, while geopolitical and fiscal strains deepened across the continent.Germany signaled…

View Post

Editor's Pick

Evening digest: Nvidia China surge, Trump crypto push, Bitcoin breakout watch

Markets are looking to kick off the year with a volatile mix of tech, geopolitics, speculative finance, and protectionism.Nvidia is racing to meet surging Chinese demand for its H200 AI…

View Post

Editor's Pick

Boeing stock dubbed a ‘top pick’ for 2026, Dan Niles explains why

Boeing (NYSE: BA) had a strong 2025, and hedge fund manager Dan Niles expects the stock to keep climbing into next year.In fact, he dubbed BA a “top pick” for…

View Post

Editor's Pick

US midday market brief: stocks sputter as Dow, S&P 500 and Nasdaq dip ahead of year-end

US stock markets slipped modestly on Wednesday, the final trading day of 2025, as traders took profits and positioned ahead of the year-end close.The S&P 500 fell approximately 0.1% to…

View Post

Editor's Pick

Is Tesla really the leader in autonomous driving?

Tesla (NASDAQ: TSLA) has rolled out its latest Full Self-Driving (FSD) version FSD v14.2.2.2 – touting smoother lane changes and improved decision-making.Yet despite billionaire Elon Musk’s bold promises, the system…

View Post

Editor's Pick

AMD stock sees unusual options activity as whale calls dominate

Big investors placed a flurry of options bets on Advanced Micro Devices (NASDAQ: AMD stock), according to Benzinga’s options scanner, which flagged 32 unusual trades.Calls outnumbered puts, and the largest…

View Post

Editor's Pick

Why Corcept Therapeutics stock crashed today and what comes next?

Corcept Therapeutics (NASDAQ: CORT) crashed about 50% on Dec. 31 after the FDA requested additional data to support the efficacy of relacorilant, its candidate treatment for Cushing’s syndrome.The setback cast…

View Post

Editor's Pick

Here’s what matters more than rate cuts for US housing market in 2026

Logan Mohtashami, a senior HousingWire analyst, believes mortgage rate stability – not rate cuts – will be the key driver for the US housing market in 2026.While many focus on…

View Post

Editor's Pick

Why 2025 ended with the American consumer still standing

On December 1st, famed investor Jim Cramer looked into the camera on CNBC’s Mad Money and made a provocative statement – “maybe the stretched consumer is a false narrative.”At first…

View Post

Editor's Pick

Why analysts think this company could touch $5 trillion valuation in early 2026

Analysts increasingly believe Microsoft could reach a $5 trillion market valuation in early 2026.The analysis is driven by accelerating artificial intelligence monetisation, dominance in enterprise cloud infrastructure, and expanding operating…

Popular Topics